The CHI Podcasts are produced by the Cambridge Healthtech Institute and offer in-depth interviews with research and business leaders from many facets of biotechnology.
https://www.moleculardxeurope.com/
Next Generation DX Summit 2018 | the Value of NGS-based Diagnostic Testing for Lung Cancer Patients
Daryl Pritchard of PMC speaks to CHI on May 4th, 2018. Darryl will be speaking at a shared session between the Coverage and Reimbursement for Advanced Diagnostics Track and the Precision Medicine tracks at the upcoming Next-Generation Diagnostic Summit that is held from August 20th to the 24th in Washington, D.C Topics include the chicken-or-the-egg conundrum of building evidence and gaining access, a study looking at the cost effectiveness of using NGS for clinical practice, challenges in the diagnostic reimbursement community and more. For more information, please visit http://www.NextGenerationDX.com/Reimbursement-Diagnostics/ and http://www.NextGenerationDX.com/Precision-Medicine/